Latest stories on JBSS
John B. Sanfilippo & Son, Inc. 1st Quarter Fiscal Year 2027 Operating Results Conference Call
GlobeNewswire50 · neutralearnings
John B. Sanfilippo & Son, Inc. 1st Quarter Fiscal Year 2027 Operating Results Conference Call
Business Insider50 · neutralearnings
John B. Sanfilippo Announces Leadership Transition and Promotions
TipRanks50 · neutralgeneral
SANFILIPPO JOHN B & SON INC (JBSS) files 8-K
SEC 8-K50 · neutralgeneral
Abeona Therapeutics® Congratulates Ultragenyx on U.S. FDA Approval of FAYUVI™ Gene Therapy for Sanfilippo Syndrome Type A (MPS IIIA)
Business Insider73 · bullishproduct/pr
RARE Stock Jumps 13% — Extends Gains After-Hours As FDA Clears First Sanfilippo Gene Therapy
Stocktwits News78 · bullishproduct/pr
FDA Approves First Gene Therapy for Pediatric Patients with Sanfilippo Syndrome Type A
Business Insider78 · bullishproduct/pr
FDA approves Ultragenyx gene therapy for Sanfilippo syndrome type A
The Fly73 · bullishproduct/pr
Rocket Companies names Sanfilippo Chief Executive Officer of Redfin
The Fly55 · neutralgeneral
John B. Sanfilippo Eyes $300M Bar Growth as CEO Transition Nears
Yahoo Top63 · neutralproduct/pr
Record Sales, Shrinking Profits: The Two Faces Of John B. Sanfilippo & Sons (JBSS)
Yahoo Finance42 · neutralearnings
JBSS Q4 2026 Earnings Call Transcript
Yahoo Finance63 · neutralearnings
JBSS Q4 2026 Earnings Call Transcript
The Motley Fool63 · neutralearnings
SANFILIPPO JOHN B & SON INC (JBSS) files 8-K
SEC 8-K50 · neutralgeneral
John B. Sanfilippo & Son: Don't Go Nuts Over One Tough Quarter
Seeking Alpha58 · neutralearnings
John B. Sanfilippo stock rating upgraded to Buy at Freedom Broker
Investing.com Analyst Ratings61 · neutralanalyst
JBSS outlines $300M bar capacity growth opportunity as new lines target Q2 FY2027 operation
Seeking Alpha58 · neutralproduct/pr
John B. Sanfilippo & Son, Inc. (JBSS) Q4 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
Freedom upgrades John B. Sanfilippo with sales offsetting margin pressure
The Fly58 · neutralanalyst
John B. Sanfilippo upgraded to Buy from Hold at Freedom Broker
The Fly56 · neutralanalyst
John B. Sanfilippo reports Q4 EPS 71c vs $1.15 last year
The Fly34 · bearishearnings
SANFILIPPO JOHN B & SON INC (JBSS) files 8-K
SEC 8-K50 · neutralgeneral
John B. Sanfilippo & Son, Inc. Reports Fiscal 2026 Fourth Quarter and Full Year Results
StockTitan34 · bearishearnings
John B. Sanfilippo & Son, Inc. 4th Quarter Fiscal Year 2026 Operating Results Conference Call
Business Insider50 · neutralgeneral
John B. Sanfilippo & Son, Inc. 4th Quarter Fiscal Year 2026 Operating Results Conference Call
GlobeNewswire50 · neutralgeneral